Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221232 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™
A Phase 2 study, sponsored by Zurex Pharma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT02221232 is a Phase 2 study that was terminated before completion, run by Zurex Pharma. The registered enrollment target is 64 participants.
The verdict
NCT02221232, a Phase 2 study, was terminated before completion, sponsored by Zurex Pharma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied in two different areas when used as a patient preoperative skin preparation.
Interventions
- DRUG ZuraPrep
- DRUG ZuraPrep Vehicle
- DRUG Chloraprep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02221232
The ClinicalTrials.gov registry entry for NCT02221232 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zurex Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ZuraPrep is the first listed.
NCT02221232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02221232 about?
NCT02221232 is a clinical study titled "Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™". The purpose of this pilot study is to evaluate antimicrobial properties of a single test product, a vehicle product and a reference product applied in two different areas when used as a patient preoperative skin preparation.
What is the current status of trial NCT02221232?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2014-08. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02221232?
The interventions under investigation include: ZuraPrep (DRUG), ZuraPrep Vehicle (DRUG), Chloraprep (DRUG).
Who is sponsoring clinical trial NCT02221232?
This trial is sponsored by Zurex Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.